Fusion Pharmaceuticals Inc. Shareholders' Equity
Fusion Pharmaceuticals Inc. had Shareholders' Equity of $241.83 million as of 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2024-05-07
- 2024-03-31: Stockholders' Equity Attributable to Parent $241.83M.
- 2023-12-31: Stockholders' Equity Attributable to Parent $222.48M.
- 2023-09-30: Stockholders' Equity Attributable to Parent $188.47M.
- 2023-06-30: Stockholders' Equity Attributable to Parent $202.96M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2024-03-31 | $241.83M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $222.48M 10-Q · filed 2024-05-07 |
| 2023-09-30 | $188.47M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $202.96M 10-Q · filed 2023-11-07 |
| 2023-03-31 | $200.83M 10-Q · filed 2024-05-07 |
| 2022-12-31 | $162.22M 10-Q · filed 2024-05-07 |
| 2022-09-30 | $183.14M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $198.91M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $215.43M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $231.46M 10-K · filed 2024-03-20 |
| 2021-09-30 | $246.50M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $263.55M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $279.07M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $294.51M 10-K · filed 2023-03-16 |